These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2125725)

  • 1. Vasodilator and antihypertensive actions of 3-nitropropionic acid.
    Hong E; Castillo C; Rivero I; Somanathan R
    Proc West Pharmacol Soc; 1990; 33():209-11. PubMed ID: 2125725
    [No Abstract]   [Full Text] [Related]  

  • 2. [An analysis of the antihypertensive properties of 3-nitropropionic acid, a compound from plants in the genus Astragalus].
    Castillo C; Valencia I; Reyes G; Hong E
    Arch Inst Cardiol Mex; 1993; 63(1):11-6. PubMed ID: 8466361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxant properties mediated by nitroglycerin in aortic coarctation hypertensive rats.
    Ogawa Y; Okumura K; Matsui H; Fukami Y; Saburi Y; Iami H; Mizuno T; Nishimoto Y
    Heart Vessels; 2002 Dec; 17(2):69-73. PubMed ID: 12541097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of the vasodilating effect of nitroglycerin and chlorpromazine and features of their interaction in a model of a rat isolated thoracic aorta].
    Dukhanin AS; Shilo VIu; Nikitin VB; Engalycheva GN
    Biull Eksp Biol Med; 1994 Sep; 118(9):273-6. PubMed ID: 7819558
    [No Abstract]   [Full Text] [Related]  

  • 5. Wy-46,300 and Wy-46,531: vascular smooth muscle relaxant/antihypertensive agents with combined Ca2+ antagonist/myosin phosphorylation inhibitory mechanisms.
    Silver PJ; Sulkowski TS; Lappe RW; Wendt RL
    J Cardiovasc Pharmacol; 1986; 8(6):1168-75. PubMed ID: 2434743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the cardiodepressor action of 3-nitropropionic acid.
    Castillo C; Reyes G; Rosas-Lezama MA; Valencia I; Hong E
    Proc West Pharmacol Soc; 1994; 37():41-2. PubMed ID: 7984666
    [No Abstract]   [Full Text] [Related]  

  • 7. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Nitropropionic acid induces nitric oxide release in rat arteries.
    López Sánchez P; Suárez Sagrero A; Castillo Henkel C; Escalante B
    Proc West Pharmacol Soc; 1998; 41():135-7. PubMed ID: 9836271
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitrovasodilator-induced relaxation in guinea pig vascular and tracheal smooth muscle.
    Larios FJ; Rosas-Lezama MA; Castillo C; Hong E
    Proc West Pharmacol Soc; 1995; 38():19-20. PubMed ID: 7480009
    [No Abstract]   [Full Text] [Related]  

  • 10. Amoebic relaxant derived factor with activity on vascular smooth muscle.
    Hernandez MA; Tsutsumi V; León A; Castillo C; Valencia I; Campos R
    Proc West Pharmacol Soc; 1998; 41():89-90. PubMed ID: 9836255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of NO-dependent relaxation in smooth muscles of the rat aorta with nitro compounds].
    Kovalev IV; Popov AG; Panov AA; Borodin IuL; Afinogenova IaD; Kapilevich LV; Baskakov MB; Medvedev MA
    Eksp Klin Farmakol; 2001; 64(3):33-6. PubMed ID: 11558436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
    Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
    Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on hypotensive mechanism of adrenomedullin (13-52)].
    Zhao D; Tian Q; Zhao YT; Gong CN; Han QD; Zhang ZK; Tang J
    Sheng Li Xue Bao; 1995 Jun; 47(3):218-24. PubMed ID: 7570105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
    Donà G; Giuliani P; Cremonesi P; Passaro A; Stella P; Tursi F; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S59-66. PubMed ID: 8839228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids.
    Chen KS; Ko FN; Teng CM; Wu YC
    J Nat Prod; 1996 May; 59(5):531-4. PubMed ID: 8778245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
    O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
    Smith MP; Humphrey SJ; Kerr SW; Mathews WR
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the vasodilator action of antihypertensive drug budralazine.
    Chiba T; Hirohashi M; Suzuki I; Tanaka S; Watanabe K; Akashi A
    Arzneimittelforschung; 1983; 33(1):112-6. PubMed ID: 6299307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761).
    Sweet CS; Scriabine A; Weitz D; Ludden CT; Minsker DH; Stone CA
    J Pharmacol Exp Ther; 1979 Oct; 211(1):200-6. PubMed ID: 114619
    [No Abstract]   [Full Text] [Related]  

  • 20. Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats.
    Conklin DJ; Boor PJ
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):245-51. PubMed ID: 9473532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.